Merck presents positive results from phase-II/III study EP News Bureau Jun 22, 2022 Broad phase-III clinical programme for V116 in vaccine-naïve and vaccine-experienced adults planned to start in July 2022
Dr Mansukh Mandaviya launches nation-wide expansion of PCV Press Information Bureau Nov 2, 2021 Addressing the nation-wide rollout, the Union Minister said that it is for the first time in the country that PCV will be…
Aurobindo Pharma joins COVID-19 vaccine hunt Press Trust of India Aug 8, 2020 The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022
